Award
NIH Reporter #RFA-CA-17-061
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies
Recipient
University of Cincinnati
Award Amount
$632,637.00
Ceiling
$632,637.00
Awarded
February 22, 2024
Identifier
RFA-CA-17-061
This award supports the development of novel molecular strategies for individualized leukemia therapies through an Integrated Translational Science Center, aiming to improve clinical outcomes by matching molecular profiles to targeted treatments within the National Clinical Trials Network.
Description
The project aims to develop molecular strategies for leukemia treatment within the NCTN. It focuses on identifying genetic and epigenetic markers, therapeutic targets, and integrating science into clinical trials. The project involves collaboration between the University of Cincinnati and the National Cancer Institute.